Govt constitutes 7 member panel to prepare ‘National Drugs Database’

AK Pradhan will be the convener of the committee.

781
Govt of India
Govt of India

The Union ministry of health and family welfare, Govt. of India, has constituted a seven-member panel to prepare a comprehensive ‘National Drugs Database’ of drug formulations manufactured and marketed in the country.

This will enhance regulatory oversight of medical products in the country to ensure their quality and bring uniformity to drug regulatory mechanisms across the country. 

‘National Drugs Database’

According to a notification issued by the ministry on October 27, 2022, a committee has been set up to prepare a comprehensive “National Drugs Database’.

The committee comprises:

AK Pradhan will be the convener of the committee.

The committee will check the database already in place with different authorities, including state and union territory drug control offices, the Central Drugs Standard Control Organization (CDSCO), and different producers, distributors, and importers.

Furthermore, the committee will give recommendations and come up with a comprehensive “National Drugs Database” of drug formulations produced and marketed in the country.

The database will provide detailed information on the drug:

  • Its dosage form,
  • Strength,
  • Details of the manufacturer, marketer, importer, etc.

These are crucial for not only empowering consumers but also for improving the monitoring mechanism for the quality of drugs in circulation, across the country and uniform administration of the regulatory system, etc.

The committee may co-opt any other expert as deemed necessary. In three months, the panel will deliver its recommendations to the ministry, along with the “National Drugs Database” of drug formulations.

The health ministry has increased efforts to make sure that medicines sold to people in India are secure, efficient, and meet established quality standards.

In July this year, the ministry released a draft of the Drugs, Medical Devices and Cosmetics Bill, 2022 with an aim of reviewing, replacing, and modernizing the obsolescent Drugs and Cosmetics Act, 1940 which it has been persistently reviewing and streamlining the rules to further accommodate the changes and to adopt the new technology.

The draft was prepared by an 8-member committee headed by the Drug Controller General of India, Dr. VG Somani.

DCGI to SDCs: Accept hard copy of application for registration of Medical Devices

USFDA issues Form 483 with 5 observations to Lupin

IPC introduces draft amendment to microbial contamination in IP 2022

USFDA issues Form 483 with one Observation to Laurus Labs

CDSCO Panel approves Tofacitinib Ointment 2% to Continue Clinical Trial Study

USFDA gives final approval for Paclitaxel injection

This State Pharmacy Council to appoint Pharmacy Inspectors

Medical Stores पर कार्रवाई: नशीली दवाई बेचने पर Licenses cancel, suspend

Two persons arrested in fake BP medicine racket

Latest Notifications regarding Pharmaceuticals

For informative videos on the news regarding Pharma / Medical Devices / Cosmetics / Homoeopathy etc., click on the below YouTube icon:

YouTube Icon

For informative videos by The Health Master, click on the below YouTube icon:

YouTube Icon

For informative videos on Medical Store / Pharmacy, click on the below YouTube icon:

YouTube Icon

For informative videos on the news regarding Pharma / Medical Devices / Cosmetics / Homoeopathy etc., click on the below YouTube icon:

YouTube Icon

For informative videos on consumer awareness, click on the below YouTube icon:

YouTube Icon
Telegram
WhatsApp
Facebook
LinkedIn
YouTube Icon
Google-news